Dr. Jairo Rodríguez has +20 years of experience in biomedical and basic research, both in academic and industrial settings. He received his Ph.D. from Institut d’Investigacions Biomèdiques de Bellvitge (IDIBELL) in 2008 we he was initially trained in cancer research, developing novel strategies to identify DNA methylation biomarkers that may be used in the early detection and/or management of colorectal cancer. Later, during his postdoctoral stay at Fred Hutchinson Cancer Research Center in Seattle, Dr. Rodríguez made broad use of different genomic approaches to study chromatin regulation in the context of DNA replication using budding yeast as a model organism, which earned him broad expertise in the generation and analysis of next generation sequencing data. At qGenomics, Dr. Rodríguez has directed the R&D department for the last 5 years, devising and implementing different genomic approaches where technology transfer is key, combining both wet lab and bioinformatics. Throughout the supervision of Ph.D. projects Dr. Rodriguez and his team have acquired a broad expertise in the manipulation and analysis of cell free DNA (cfDNA), mostly in the field of prenatal diagnosis and cancer monitoring. They have also developed methodologies that allow them to precisely identify ultra rare mutations in cfDNA with extreme accuracy to perform tumor monitoring. Looking into the future, Dr. Rodríguez’ long-term goals at qGenomics are to facilitate the diagnosis and monitoring of high-impact human diseases.